Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

COCP Cocrystal Pharma, Inc. Common Stock
$0.98 -0.23% 0.00
Notify me if price changes either direction
Interactive Brokers Logotype

Buy COCP stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades

Cocrystal Pharma, Inc. Common Stock (COCP)

Loading

Key Stats

Market cap. 18.8M
Enterprise value 15.3M
Trailing PE -1.2561538280585
Forward PE -2.0633683
PEG Ratio -0.083743588537233
Enterprise to EBITDA -1.332
Enterprise to revenue 35.093
Price to book MRQ 12.896052
Price to sales TTM 43.40198

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
Revenue (TTM) 435.0K
EBITDA -11461000
Diluted EPS TTM -0.76
Total Cash (MRQ) 4.9M
Current ratio (MRQ) 1.722
Operating Cash Flow (TTM) -8192000

COCP trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent COCP News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.